# A Study of Quinacrine in Participants With Cutaneous Lupus Erythematosus

> **NCT07694336** · PHASE2 · RECRUITING · sponsor: **Victoria Werth** · enrollment: 24 (estimated)

## Conditions studied

- Cutaneous Lupus Erythematosus (CLE)

## Interventions

- **DRUG:** Quinacrine Hydrochloride
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07694336
- **Lead sponsor:** Victoria Werth
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-30
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07694336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07694336, "A Study of Quinacrine in Participants With Cutaneous Lupus Erythematosus". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07694336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*